Tokumi Fujikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tokumi Fujikawa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Shigeto Yamawaki
Department of Psychiatry and Neurosciences, Division Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
3 shared publications- Shigeto Yamawaki
Hiroshima University
2 shared publications Akiko Kinoshita
1 shared publicationAkiko Kurata
1 shared publication- Akio Mantani
Yoshida General Hospital, Hiroshima, Japan
1 shared publication Hidehisa Yamashita
1 shared publication
Latest Publications
- 1 January 2012
- Vol. 114 (3) , 283-8
[Is depression a risk factor of dementia? Neurovascular depression and cognition disorders].
- 1 January 2012
- Vol. 114 (3) , 283-8
[Is depression a risk factor of dementia? Neurovascular depression and cognition disorders].
- 1 April 2008
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 16 (4) , 336-337
Methylphenidate in the Treatment of Geriatric Patients With Vascular Depression: A Retrospective Chart Review
- 1 April 2008
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 16 (4) , 336-337
Methylphenidate in the Treatment of Geriatric Patients With Vascular Depression: A Retrospective Chart Review
- 1 May 2004
- Published by S. Karger AG in Neuropsychobiology
- Vol. 49 (4) , 201-204
Quetiapine Treatment for Behavioral and Psychological Symptoms in Patients with Senile Dementia of Alzheimer Type
The purpose of this study was to assess the effect of quetiapine in the treatment of behavioral and psychological symptoms of dementia (BPSD) in patients with senile dementia of Alzheimer type (SDAT). Sixteen SDAT patients with BPSD were recruited and quetiapine (25– 200 mg/day) was prescribed for 8 weeks. BPSD were evaluated with the Behavioral Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD) and Cohen-Mansfield Agitation Inventory (CMAI) at week 0 (baseline) and week 8 (endpoint). The severity of the extrapyramidal symptoms was also assessed by the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) at baseline and endpoint. Significant improvements were seen in the CMAI total score and in the BEHAVE-AD subscales of delusions, activity disturbances, aggressiveness, diurnal rhythm disturbances and in the BEHAVE-AD overall severity. There was no significant difference between the baseline and endpoint in the DIEPSS score. These data indicate that quetiapine is effective in controlling BPSD with favorable adverse-event profiles.
- 1 May 2004
- Published by S. Karger AG in Neuropsychobiology
- Vol. 49 (4) , 201-204
Quetiapine Treatment for Behavioral and Psychological Symptoms in Patients with Senile Dementia of Alzheimer Type
The purpose of this study was to assess the effect of quetiapine in the treatment of behavioral and psychological symptoms of dementia (BPSD) in patients with senile dementia of Alzheimer type (SDAT). Sixteen SDAT patients with BPSD were recruited and quetiapine (25– 200 mg/day) was prescribed for 8 weeks. BPSD were evaluated with the Behavioral Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD) and Cohen-Mansfield Agitation Inventory (CMAI) at week 0 (baseline) and week 8 (endpoint). The severity of the extrapyramidal symptoms was also assessed by the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) at baseline and endpoint. Significant improvements were seen in the CMAI total score and in the BEHAVE-AD subscales of delusions, activity disturbances, aggressiveness, diurnal rhythm disturbances and in the BEHAVE-AD overall severity. There was no significant difference between the baseline and endpoint in the DIEPSS score. These data indicate that quetiapine is effective in controlling BPSD with favorable adverse-event profiles.
- 1 November 1996
- Published by Wolters Kluwer Health in Stroke
- Vol. 27 (11) , 2040-2042
Response of Patients With Major Depression and Silent Cerebral Infarction to Antidepressant Drug Therapy, With Emphasis on Central Nervous System Adverse Reactions
Background and Purpose We previously found that silent cerebral infarction (SCI) is present in most patients older than 50 years with major depression. The present study was designed to clarify the response to antidepressant pharmacotherapy in patients with major depression associated with SCI. Methods Using clinical charts, we retrospectively studied patients older than 50 years who were admitted for antidepressant drug therapy. Patients with bipolar affective disorder and those with focal neurological symptoms were excluded. All patients underwent magnetic resonance imaging and were classified as SCI-negative or SCI-positive. The SCI-positive group was subclassified into those with moderate SCI (either perforating area or cortical area) (n=15) and those with severe SCI (both perforating and cortical areas) (n=7). Duration of treatment in hospital and the incidence of central nervous system adverse reactions to the antidepressant drugs were compared between the two groups. Results The duration of hospital treatment in patients with severe SCI was significantly longer than in those with moderate SCI ( P <.01). The percentage of patients with adverse central nervous system reactions to antidepressant drugs was significantly higher in the SCI-positive group than in the SCI-negative group ( P <.05). Patients with severe SCI had significantly more adverse reactions than those with moderate SCI ( P <.05). Conclusions Depressed patients with severe SCI required longer hospital treatment and had more drug-related adverse reactions of the central nervous system. These findings suggest that the depression associated with severe SCI may be resistant to treatment.
- 1 November 1996
- Published by Wolters Kluwer Health in Stroke
- Vol. 27 (11) , 2040-2042
Response of Patients With Major Depression and Silent Cerebral Infarction to Antidepressant Drug Therapy, With Emphasis on Central Nervous System Adverse Reactions
Background and Purpose We previously found that silent cerebral infarction (SCI) is present in most patients older than 50 years with major depression. The present study was designed to clarify the response to antidepressant pharmacotherapy in patients with major depression associated with SCI. Methods Using clinical charts, we retrospectively studied patients older than 50 years who were admitted for antidepressant drug therapy. Patients with bipolar affective disorder and those with focal neurological symptoms were excluded. All patients underwent magnetic resonance imaging and were classified as SCI-negative or SCI-positive. The SCI-positive group was subclassified into those with moderate SCI (either perforating area or cortical area) (n=15) and those with severe SCI (both perforating and cortical areas) (n=7). Duration of treatment in hospital and the incidence of central nervous system adverse reactions to the antidepressant drugs were compared between the two groups. Results The duration of hospital treatment in patients with severe SCI was significantly longer than in those with moderate SCI ( P <.01). The percentage of patients with adverse central nervous system reactions to antidepressant drugs was significantly higher in the SCI-positive group than in the SCI-negative group ( P <.05). Patients with severe SCI had significantly more adverse reactions than those with moderate SCI ( P <.05). Conclusions Depressed patients with severe SCI required longer hospital treatment and had more drug-related adverse reactions of the central nervous system. These findings suggest that the depression associated with severe SCI may be resistant to treatment.
- Open Access
- 1 January 1993
- Published by Japan Stroke Society in Japanese Journal of Stroke
- Vol. 15 (1) , 18-22
Occurrence of silent cerebral infarction in pre-senile, senile subjects with depressive states. MRI findings and its distribution.
- 1 January 1993
- Published by Japan Stroke Society in Japanese Journal of Stroke
- Vol. 15 (1) , 18-22
Open AccessOccurrence of silent cerebral infarction in pre-senile, senile subjects with depressive states. MRI findings and its distribution.